We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8464:TWSENien Made Enterprise Co., Ltd. Analysis

Data as of 2026-07-18 - not real-time

NT$359.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nien Made Enterprise is trading just above its short‑term moving average while remaining below its longer‑term trend line, indicating a price that is modestly supported but still faces upward resistance. The momentum gauges are neutral, with the RSI in the middle range and the MACD histogram turning negative, suggesting short‑term bearish pressure despite a generally neutral market trend. Fundamentally, the company delivers strong profitability margins, a solid return on equity, and a healthy free cash flow generation that comfortably covers its dividend payouts.
The dividend yield is notably high and the payout ratio is sustainable, backed by ample cash reserves and low leverage. However, the discounted cash flow model values the stock well below the current market price, pointing to an overvalued condition in the near term. Investors should weigh the attractive income profile against the valuation gap and the modest revenue growth outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish MACD histogram indicating short‑term downside pressure
  • price sitting near a key support level
  • decreasing volume trend reducing immediate upside momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • strong cash generation and low debt supporting dividend sustainability
  • robust operating and profit margins offering resilience
  • analyst consensus skewed toward a strong‑buy outlook

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • consistent high dividend yield with a comfortable payout ratio
  • stable ROE and ROA indicating efficient capital use
  • low beta and defensive consumer‑cyclical positioning limiting market volatility

Key Metrics & Analysis

Financial Health

Revenue Growth0.40%
Profit Margin21.57%
P/E Ratio16.0
ROE25.39%
ROA13.42%
Debt/Equity6.13
P/B Ratio3.9
Op. Cash FlowNT$7.9B
Free Cash FlowNT$5.1B

Technical Analysis

TrendNeutral
RSI53.0
SupportNT$338.50
ResistanceNT$380.50
MA 20NT$358.18
MA 50NT$340.25
MA 200NT$374.50
MACDBearish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair ValueNT$292.34
Target PriceNT$483.20
Upside/Downside34.60%
GradeOvervalued
TypeValue
Dividend Yield4.46%

Risk Assessment

Beta0.37
Volatility34.58%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.